Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Brufsky

Showing results (21-30 of 193) with videos related to

Pageof 20
Sort By:
The Breast Journal|December 27, 2019
Adjuvant bisphosphonate therapy in early-stage breast cancer-Treating the soil to kill the seedAdam Brufsky, Aju Mathew
Future Oncology (London, England)|February 15, 2020
Neratinib: the emergence of a new player in the management of HER2+ breast cancer brain metastasisAzadeh Nasrazadani, Adam Brufsky
Lancet (London, England)|July 28, 2015
Bisphosphonates, bone, and breast cancer recurrenceAdam Brufsky, Aju Mathew
Nature Reviews. Clinical Oncology|September 10, 2014
Breast cancer: Zoledronic acid--more than just a bone drugAju Mathew, Adam Brufsky
The Lancet. Oncology|November 19, 2013
Treatment of HER2-positive breast cancer: looking backwards brieflyShannon Puhalla, Adam Brufsky
Targeted Oncology|May 6, 2023
P-REALITY X: A Real-World Analysis of Palbociclib Plus an Aromatase Inhibitor in HR+/HER2- Metastatic Breast Cancer-A PodcastAdam Brufsky, Christopher Gallagher
Biologics : Targets & Therapy|August 27, 2009
Ixabepilone: a new chemotherapeutic option for refractory metastatic breast cancerShannon Puhalla, Adam Brufsky
Breast Cancer (Dove Medical Press)|December 25, 2013
Decreased risk of breast cancer associated with oral bisphosphonate therapyAju Mathew, Adam Brufsky
Journal of Medical Virology|May 7, 2020
DC/L-SIGNs of hope in the COVID-19 pandemicAdam Brufsky, Michael T Lotze
Journal of Medical Virology|May 28, 2020
Ratcheting down the virulence of SARS-CoV-2 in the COVID-19 pandemicAdam Brufsky, Michael T Lotze
Pageof 20

Showing results (21-30 of 193) with videos related to

Sort By:
Pageof 20
The Breast Journal|December 27, 2019
Adjuvant bisphosphonate therapy in early-stage breast cancer-Treating the soil to kill the seedAdam Brufsky, Aju Mathew
Future Oncology (London, England)|February 15, 2020
Neratinib: the emergence of a new player in the management of HER2+ breast cancer brain metastasisAzadeh Nasrazadani, Adam Brufsky
Lancet (London, England)|July 28, 2015
Bisphosphonates, bone, and breast cancer recurrenceAdam Brufsky, Aju Mathew
Nature Reviews. Clinical Oncology|September 10, 2014
Breast cancer: Zoledronic acid--more than just a bone drugAju Mathew, Adam Brufsky
The Lancet. Oncology|November 19, 2013
Treatment of HER2-positive breast cancer: looking backwards brieflyShannon Puhalla, Adam Brufsky
Targeted Oncology|May 6, 2023
P-REALITY X: A Real-World Analysis of Palbociclib Plus an Aromatase Inhibitor in HR+/HER2- Metastatic Breast Cancer-A PodcastAdam Brufsky, Christopher Gallagher
Biologics : Targets & Therapy|August 27, 2009
Ixabepilone: a new chemotherapeutic option for refractory metastatic breast cancerShannon Puhalla, Adam Brufsky
Breast Cancer (Dove Medical Press)|December 25, 2013
Decreased risk of breast cancer associated with oral bisphosphonate therapyAju Mathew, Adam Brufsky
Journal of Medical Virology|May 7, 2020
DC/L-SIGNs of hope in the COVID-19 pandemicAdam Brufsky, Michael T Lotze
Journal of Medical Virology|May 28, 2020
Ratcheting down the virulence of SARS-CoV-2 in the COVID-19 pandemicAdam Brufsky, Michael T Lotze
Pageof 20